{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:53:54Z","timestamp":1789275234451,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"National Institute of Biomedical Genomics, Kalyani"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.aohep.2020.06.009","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T11:51:31Z","timestamp":1594813891000},"page":"472-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis"],"prefix":"10.1016","volume":"19","author":[{"given":"Ankita","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analabha","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipankar","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswanath","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Roychoudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha P.","family":"Majumder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyadarshi","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2020.06.009_bib0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: what we need in the future","volume":"38","author":"Ara\u00fajo","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2020.06.009_bib0010","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science (80-)"},{"key":"10.1016\/j.aohep.2020.06.009_bib0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2020.06.009_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d3897","article-title":"How big a problem is non-alcoholic fatty liver disease?","volume":"343","author":"Anstee","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.aohep.2020.06.009_bib0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/hep.21327","article-title":"Long-term follow-up of patients with NAFLD and elevated liver enzymes","volume":"44","author":"Ekstedt","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.06.009_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2020.06.009_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.06.009_bib0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MOG.0b013e328337b0c4","article-title":"Recent advances in nonalcoholic fatty liver disease","volume":"26","author":"Cheung","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.aohep.2020.06.009_bib0045","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2337\/dc17-1902","article-title":"Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis","volume":"41","author":"Mantovani","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.aohep.2020.06.009_bib0050","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.06.009_bib0055","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.30429","article-title":"Modulation of insulin resistance in nonalcoholic fatty liver disease","volume":"70","author":"Khan","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.06.009_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01566","article-title":"Potential nexus of non-alcoholic fatty liver disease and type 2 diabetes mellitus: insulin resistance between hepatic and peripheral tissues","volume":"9","author":"Mu","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.aohep.2020.06.009_bib0065","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1042\/CS20170261","article-title":"Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes","volume":"131","author":"Brouwers","year":"2017","journal-title":"Clin Sci"},{"key":"10.1016\/j.aohep.2020.06.009_bib0070","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2337\/db15-1552","article-title":"Insulin regulates hepatic triglyceride secretion and lipid content via signaling in the brain","volume":"65","author":"Scherer","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.aohep.2020.06.009_bib0075","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00599","article-title":"Integrated analysis of multiple microarray studies to identify novel gene signatures in non-alcoholic fatty liver disease","volume":"10","author":"Jia","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.aohep.2020.06.009_bib0080","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/hep.27695","article-title":"Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids","volume":"61","author":"Arendt","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.06.009_bib0085","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/hep.26455","article-title":"Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials","volume":"58","author":"Noureddin","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.06.009_bib0090","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00330-010-1905-5","article-title":"The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis","volume":"21","author":"Bohte","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.aohep.2020.06.009_bib0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.aohep.2020.06.009_bib0100","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1210\/jc.2010-0288","article-title":"The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp","volume":"95","author":"Guerrero-Romero","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.aohep.2020.06.009_bib0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4274\/Jcrpe.1127","article-title":"A Study of insulin resistance by HOMA-IR and its cut-off value to identify metabolic syndrome in urban Indian adolescents","volume":"5","author":"Singh","year":"2013","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/j.aohep.2020.06.009_bib0110","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.06.009_bib0115","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.06.009_bib0120","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.aohep.2020.06.009_bib0125","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","article-title":"DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery","volume":"18","author":"Ahrens","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2020.06.009_bib0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/hep.26661","article-title":"Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease","volume":"59","author":"Moylan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.06.009_bib0135","unstructured":"[dataset][27]GSE48452[Accession] - GEO DataSets - NCBI n.d. https:\/\/www.ncbi.nlm.nih.gov\/gds\/?term=GSE48452%5BAccession%5D. [Accessed 27 June 2020)."},{"key":"10.1016\/j.aohep.2020.06.009_bib0140","unstructured":"[dataset] [28]GSE89632[Accession] - GEO DataSets - NCBI n.d. https:\/\/www.ncbi.nlm.nih.gov\/gds\/?term=GSE89632%5BAccession%5D. [Accessed 27 June 2020]."},{"key":"10.1016\/j.aohep.2020.06.009_bib0145","unstructured":"[dataset] [29]GSE49541[Accession] - GEO DataSets - NCBI n.d. https:\/\/www.ncbi.nlm.nih.gov\/gds\/?term=GSE49541%5BAccession%5D. [Accessed 27 June 2020]."},{"key":"10.1016\/j.aohep.2020.06.009_bib0150","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/bioinformatics\/btm254","article-title":"GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor","volume":"23","author":"Sean","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.aohep.2020.06.009_bib0155","doi-asserted-by":"crossref","DOI":"10.1152\/ajpgi.00077.2013","article-title":"Genome-wide transcriptome analysis identifies novel gene signatures implicated in human chronic liver disease","volume":"305","author":"Smalling","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.aohep.2020.06.009_bib0160","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120274","article-title":"Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes","volume":"3","author":"Ramnath","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.aohep.2020.06.009_bib0165","doi-asserted-by":"crossref","DOI":"10.1080\/10618600.1996.10474713","article-title":"R: a language for data analysis and graphics","volume":"5","author":"Ihaka","year":"1996","journal-title":"J Comput Graph Stat"},{"key":"10.1016\/j.aohep.2020.06.009_bib0170","unstructured":"STRING v11: Protein-Protein Association Networks With Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/30476243\/. [Accessed 27 June 2020]."},{"key":"10.1016\/j.aohep.2020.06.009_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkn923","article-title":"Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists","volume":"37","author":"Huang","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.aohep.2020.06.009_bib0180","doi-asserted-by":"crossref","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals","volume":"316","author":"Suppli","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.aohep.2020.06.009_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease as a Nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2020.06.009_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2020.06.009_bib0195","article-title":"Relationship between fat mass and obesity-associated gene expression and type 2 diabetes mellitus severity","volume":"15","author":"Wang","year":"2018","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.aohep.2020.06.009_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033264","article-title":"Zinc-alpha 2-glycoprotein gene expression in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients","volume":"7","author":"Garrido-S\u00e1nchez","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2020.06.009_bib0205","article-title":"Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes","volume":"17","author":"Shen","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.aohep.2020.06.009_bib0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molmet.2015.12.004","article-title":"Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients","volume":"5","author":"Kirchner","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.aohep.2020.06.009_bib0215","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3892\/etm.2011.328","article-title":"Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease","volume":"2","author":"Higuchi","year":"2011","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.aohep.2020.06.009_bib0220","article-title":"Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases","volume":"2014","author":"Furuhashi","year":"2014","journal-title":"Clin Med Insights Cardiol"},{"key":"10.1016\/j.aohep.2020.06.009_bib0225","doi-asserted-by":"crossref","DOI":"10.2174\/187152511794182855","article-title":"CD36 as a multiple-ligand signaling receptor in atherothrombosis","volume":"9","author":"Nergiz-Unal","year":"2011","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.aohep.2020.06.009_bib0230","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5009\/gnl15226","article-title":"The role of mesothelial cells in liver development, injury, and regeneration","volume":"10","author":"Lua","year":"2016","journal-title":"Gut Liver"},{"key":"10.1016\/j.aohep.2020.06.009_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/472432","article-title":"Roles for PI3K\/AKT\/PTEN pathway in cell signaling of nonalcoholic fatty liver disease","volume":"2013","author":"Matsuda","year":"2013","journal-title":"ISRN Endocrinol"},{"key":"10.1016\/j.aohep.2020.06.009_bib0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046584","article-title":"Gene expression profiling unravels cancer-related hepatic molecular signatures in steatohepatitis but not in steatosis","volume":"7","author":"Starmann","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.aohep.2020.06.009_bib0245","unstructured":"Home - Gene - NCBI. https:\/\/www.ncbi.nlm.nih.gov\/gene. [Accessed 27 June 2020]."},{"key":"10.1016\/j.aohep.2020.06.009_bib0250","unstructured":"GeneCards - Human Genes | Gene Database | Gene Search. https:\/\/www.genecards.org\/. [Accessed 27 June 2020]."},{"key":"10.1016\/j.aohep.2020.06.009_bib0255","unstructured":"UniProt. https:\/\/www.uniprot.org\/. Accessed 27 Jun 2020."},{"key":"10.1016\/j.aohep.2020.06.009_bib0260","unstructured":"STRING: functional protein association networks. https:\/\/string-db.org\/. [Accessed 27 June 2020]."}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:42:33Z","timestamp":1761648153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268120300703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1665268120300703"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2020.06.009","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic transcriptome signature correlated with HOMA-IR explains early nonalcoholic fatty liver disease pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2020.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}